EP3544618 - MODIFIED CELL EXPANSION AND USES THEREOF [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 03.10.2024 Database last updated on 29.10.2024 | |
Former | Examination is in progress Status updated on 18.03.2022 | ||
Former | Request for examination was made Status updated on 07.02.2020 | ||
Former | The application has been published Status updated on 30.08.2019 | ||
Former | The international publication has been made Status updated on 19.07.2019 | ||
Former | unknown Status updated on 24.01.2019 | Most recent event Tooltip | 03.10.2024 | Withdrawal of application | published on 06.11.2024 [2024/45] | Applicant(s) | For all designated states Innovative Cellular Therapeutics Inc. 1405 Research Boulevard, Suite 210 Rockville, MD 20850 / US | For all designated states Innovative Cellular Therapeutics Holdings, Ltd. Suite 5-204, 23 Line Tree Bay Avenue P.O. Box 2547 Grand Cayman, KYI - 1104 / KY | [2021/16] |
Former [2019/40] | For all designated states Innovative Cellular Therapeutics Inc. 1405 Research Boulevard, Suite 210 Rockville, MD 20850 / US | ||
For all designated states Innovative Cellular Therapeutics Co., Ltd. Building 1, 6055 Jinhai Road Fengxian District Shanghai 201203 / CN | Inventor(s) | 01 /
XIAO, Lei Building 1, 6055 Jinhai Road Fengxian District Shanghai 201203 / CN | 02 /
PU, Chengfei Building 1, 6055 Jinhai Road Fengxian District Shanghai 2012023 / CN | 03 /
CAO, Zhizuan Building 1, 6055 Jinhai Road Fengxian District Shanghai 201203 / CN | 04 /
WU, Zhao Building 1, 6055 Jinhai Road Fengxian District Shanghai 201203 / CN | 05 /
MAO, Li Building 1, 6055 Jinhai Road Fengxian District Shanghai 201203 / CN | 06 /
BI, Mao Building 1, 6055 Jinhai Road Fengxian District Shanghai 201203 / CN | [2019/40] | Representative(s) | Abel & Imray LLP Westpoint Building James Street West Bath BA1 2DA / GB | [N/P] |
Former [2019/40] | Abel & Imray Westpoint Building James Street West Bath BA1 2DA / GB | Application number, filing date | 19700326.2 | 10.01.2019 | [2019/40] | WO2019US13068 | Priority number, date | US201862616079P | 11.01.2018 Original published format: US 201862616079 P | US201862616609P | 12.01.2018 Original published format: US 201862616609 P | US201862622601P | 26.01.2018 Original published format: US 201862622601 P | US201862626781P | 06.02.2018 Original published format: US 201862626781 P | US201862659114P | 17.04.2018 Original published format: US 201862659114 P | US201862659233P | 18.04.2018 Original published format: US 201862659233 P | US201862678836P | 31.05.2018 Original published format: US 201862678836 P | US201862687059P | 19.06.2018 Original published format: US 201862687059 P | US201862690892P | 27.06.2018 Original published format: US 201862690892 P | US201862721791P | 23.08.2018 Original published format: US 201862721791 P | US201816146218 | 28.09.2018 Original published format: US201816146218 | [2019/40] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019140100 | Date: | 18.07.2019 | Language: | EN | [2019/29] | Type: | A1 Application with search report | No.: | EP3544618 | Date: | 02.10.2019 | Language: | EN | The application published by WIPO in one of the EPO official languages on 18.07.2019 takes the place of the publication of the European patent application. | [2019/40] | Search report(s) | International search report - published on: | US | 18.07.2019 | (Supplementary) European search report - dispatched on: | EP | 13.01.2020 | Classification | IPC: | A61K35/17, A61K48/00, A61K39/00, C07K16/28, C07K16/30, A61P35/00 | [2019/49] | CPC: |
C12N5/0636 (EP,US);
A61K39/4611 (EP,US);
A61K39/4631 (EP,US);
A61K39/464402 (EP,US);
A61K39/464412 (EP,US);
A61K39/46447 (EP,US);
A61P35/00 (EP);
C07K14/7051 (EP);
C07K16/28 (EP);
C07K16/2803 (EP);
C07K16/2878 (EP);
C07K16/2896 (EP);
C07K16/3092 (EP);
C12N15/625 (US);
C12N15/86 (US);
A61K2039/507 (EP);
A61K2039/572 (EP);
C07K2317/622 (EP);
C07K2317/70 (EP);
C07K2319/03 (EP);
C07K2319/33 (EP);
|
Former IPC [2019/40] | A61K35/17, A61K48/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/11] |
Former [2019/40] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Title | German: | MODIFIZIERTE ZELLEXPANSION UND VERWENDUNGEN DAVON | [2019/40] | English: | MODIFIED CELL EXPANSION AND USES THEREOF | [2019/40] | French: | EXPANSION CELLULAIRE MODIFIÉE ET SES UTILISATIONS | [2019/40] | Entry into regional phase | 23.01.2019 | National basic fee paid | 23.01.2019 | Search fee paid | Examination procedure | 30.01.2020 | Examination requested [2020/11] | 30.01.2020 | Date on which the examining division has become responsible | 19.08.2020 | Amendment by applicant (claims and/or description) | 17.03.2022 | Despatch of a communication from the examining division (Time limit: M06) | 23.09.2022 | Reply to a communication from the examining division | 27.09.2024 | Application withdrawn by applicant [2024/45] | 08.11.2024 | Date of oral proceedings | Divisional application(s) | EP19180127.3 / EP3586852 | Request for further processing for: | The application is deemed to be withdrawn due to non-payment of the examination fee | 30.01.2020 | Request for further processing filed | 30.01.2020 | Full payment received (date of receipt of payment) Request granted | 11.02.2020 | Decision despatched | The application is deemed to be withdrawn due to non-payment of designation fees TR, SM, SK, SI, SE, RS, RO, PT, PL, NO, NL, MT, MK, MC, LV, LU, LT, IT, IS, IE, HU, HR, GR, GB, FR, FI, ES, EE, DK, DE, CZ, CY, CH, BG, BE, AT, AL | 30.01.2020 | Request for further processing filed | 30.01.2020 | Full payment received (date of receipt of payment) Request granted | 11.02.2020 | Decision despatched | Fees paid | Renewal fee | 27.01.2021 | Renewal fee patent year 03 | 26.01.2022 | Renewal fee patent year 04 | 26.01.2023 | Renewal fee patent year 05 | 25.01.2024 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO2012079000 (UNIV PENNSYLVANIA [US], et al); | [X]WO2017149515 (NOVARTIS AG [CH], et al); | [A]WO2017167217 (INNOVATIVE CELLULAR THERAPEUTICS CO LTD [CN]); | International search | [A]US2005079170 (LE GALL FABRICE [DE], et al); | [A]US2014227237 (JUNE CARL H [US], et al); | [A]US2014271635 (BROGDON JENNIFER [US], et al); | [X]WO2017027291 (SEATTLE CHILDREN'S HOSPITAL (DBA SEATTLE CHILDREN'S RES INSTITUTE) [US]); | [Y]US2017145108 (SCHREIBER HANS [US], et al); | [XYA]WO2017149515 (NOVARTIS AG [CH], et al); | [A]WO2017172981 (UNIV SOUTHERN CALIFORNIA [US]) | by applicant | FR901228 | US2008131962 | US8518405 | US8906682 |